Canaccord Starts Eton Pharmaceuticals (ETON) at Buy
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Price: $56.48 -2.42%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Canaccord analyst Gary Newman initiates coverage on Eton Pharmaceuticals (NASDAQ: ETON) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Eton Pharmaceuticals click here. For more ratings news on Eton Pharmaceuticals click here.
Shares of Eton Pharmaceuticals closed at $38.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
- Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
